Wogonin inhibits multiple myeloma-stimulated angiogenesis via c-Myc/VHL/HIF-1α signaling axis.

Rong Fu,Yan Chen,Xiao-Ping Wang,Teng An,Lei Tao,Yu-Xin Zhou,Yu-Jie Huang,Bao-An Chen,Zhi-Yu Li,Qi-Dong You,Qing-Long Guo,Zhao-Qiu Wu

DOI: https://doi.org/10.18632/oncotarget.6796

2016-01-01

Oncotarget

Abstract:Angiogenesis is associated with the progression of multiple myeloma (MM). Wogonin is an active mono-flavonoid with remarkable antitumor activity. However, its impact on MM-stimulated angiogenesis remains largely unknown. Here, we demonstrated that wogonin decreased expression and secretion of pro-angiogenic factors in MM cells via c-Myc/HIF-1a signaling axis, reducing MM-stimulated angiogenesis and MM cell proliferation in vivo. Overexpression of c-Myc in MM cells disrupted the balance between VHL SUMOylation and ubiquitination, and thus inhibited proteasome-mediated HIF-1a degradation. Impaired function of VHL ubiquitination complex in c-Myc-overexpressing cells was fully reversed by wogonin treatment via increasing HIF-1a-VHL interaction and promoting HIF-1a degradation. Collectively, our in vitro and in vivo studies reveal for the first time that wogonin represses MM-stimulated angiogenesis and tumor progression via c-Myc/VHL/HIF-1a signaling axis.